Sunday, Nov. 22, 2026 A Vik Media Group publication
Mongevity Longevity in Motion
Leer en español

Pancreatic cancer trial: Tumor Treating Fields delayed worsening pain

☕ Includes a question for the family ↓

Pancreatic cancerPart of a story we are following · 4 articles · See every update
A smiling woman holds a cup of coffee while sitting at a desk with a laptop.
A smiling woman holds a cup of coffee while sitting at a desk with a laptop.Photo: Shixart1985 / Wikimedia Commons, CC BY 2.0

If you or someone you love is facing pancreatic cancer, comfort day to day matters as much as the numbers on a scan. A new look at a large trial suggests one added treatment may help keep pain and everyday well-being steadier for longer.

In a trial of 571 adults with locally advanced pancreatic cancer that could not be removed by surgery, people who added Tumor Treating Fields to their chemotherapy went longer before their pain got worse and needed opioid pain medicine later than people who had chemotherapy alone.

How the study worked

This was a randomized clinical trial, the kind where chance decides who gets which treatment. It was called PANOVA-3 and ran in many countries. Adults who had not been treated before were split into two equal groups. One group got chemotherapy (gemcitabine and nab-paclitaxel) plus Tumor Treating Fields. The other got the same chemotherapy alone. This report is a planned follow-up analysis published in JAMA Network Open on November 2, 2026. Patients and doctors knew who got which treatment, and the pain medicine comparison was added after the trial ended, so treat those results as a helpful signal rather than the last word.

People filled out standard questionnaires about how they felt, covering overall health, digestion and pain. Of those in the trial, 562 completed the first questionnaire, and the researchers followed quality of life for 26 months.

What they found

The main news is about how long people stayed steady before things got worse. Scientists call this “deterioration-free time.” It simply means how many months passed before a person’s score slipped in a meaningful way.

Overall health status stayed stable in both groups during the follow-up. But the group that added Tumor Treating Fields had more months before their scores dropped. Their pain, pancreatic pain and digestive symptoms also improved starting about 2 months after treatment began, and that continued through treatment and follow-up.

Here are the typical (median) times before things got worse:

What was measured With Tumor Treating Fields Chemotherapy alone
Overall health status 7.1 months 5.7 months
Pain 10.1 months 7.4 months
Pancreatic pain 14.7 months 10.2 months
Time until opioid pain medicine was used 9.3 months 6.7 months

In plain terms, pain took roughly 10 months to worsen with the added treatment, compared with about 7 months without it. The exact figures were 10.1 and 7.4 months.

Most digestive symptoms also stayed steady longer with the added treatment. Two were the same in both groups: indigestion and changes in bowel habits.

The researchers concluded that the added treatment gave meaningful benefits for pain and quality of life. An earlier report from the same trial had already shown a survival benefit and that people tolerated the treatment. This new analysis adds the part many families care about most: how people feel while being treated.

What does “quality of life” mean here?

It is not a vague idea. The questionnaires ask concrete things: how much pain you have, how your stomach and digestion feel, and how you rate your overall health. When those scores hold steady for more months, that is more time feeling like yourself.

What you can do today

Start a simple comfort log. Once a day, jot down a pain score from 0 to 10, how your digestion felt, and how your energy was. Use a notebook or the notes app on your phone. After a week or two, you will have a clear picture to share at the next appointment, so questions about pain and comfort can be part of every treatment conversation.

Talk about it at home

Scientists wanted to know whether adding a special helper to a treatment could keep people feeling comfortable for more months. They split a large group of volunteers into teams by chance, a bit like drawing names from a hat, so the only real difference between the teams was that helper. Then they asked everyone, again and again, how they felt, the way a coach checks in with players during a long season.

Try it at home

Ask a grandparent or an older neighbor what people did when they felt achy back when they were young, and how they decided what really helped.

Keep exploring

Copies this article and its questions so you can paste them into ChatGPT, Claude, Gemini or the AI you use, and keep the conversation going.

Got a question? Ask us ›

Get the best of longevity science by emailThe most useful new studies, in plain language and with the source. Free.

We'll email you once to confirm. Occasional messages from our sponsors, clearly labeled. Unsubscribe anytime. We never ask for health data.
Cite this article
AMA
Mongevity Desk. Pancreatic cancer trial: Tumor Treating Fields delayed worsening pain. Mongevity. Published November 13, 2026. Accessed November 22, 2026. https://mongevity.science/cancer/2026/11/pancreatic-cancer-tumor-treating-fields-pain-quality-of-life/
Vancouver
Mongevity Desk. Pancreatic cancer trial: Tumor Treating Fields delayed worsening pain [Internet]. Mongevity; 2026 Nov 13 cited 2026 Nov 22]. Available from: https://mongevity.science/cancer/2026/11/pancreatic-cancer-tumor-treating-fields-pain-quality-of-life/
APA
Mongevity Desk. (2026, November 13). Pancreatic cancer trial: Tumor Treating Fields delayed worsening pain. Mongevity. https://mongevity.science/cancer/2026/11/pancreatic-cancer-tumor-treating-fields-pain-quality-of-life/
For your website
<a href="https://mongevity.science/cancer/2026/11/pancreatic-cancer-tumor-treating-fields-pain-quality-of-life/">Pancreatic cancer trial: Tumor Treating Fields delayed worsening pain</a>

Free to share or quote with credit and a link.

Questions and answers

What are Tumor Treating Fields?
It is a treatment that was added to standard chemotherapy (gemcitabine and nab-paclitaxel) in this trial. The study looked at how it affected pain and quality of life.
Who was in the study?
Adults with locally advanced pancreatic cancer that could not be removed by surgery and who had not been treated before. In all, 571 people were randomly placed into two groups.
Did the added treatment help with pain?
Pain took longer to get worse with it: about 10 months versus about 7 months with chemotherapy alone. People also started opioid pain medicine later.
Did everything improve?
Not everything. Indigestion and changes in bowel habits were similar in both groups. Overall health status stayed stable in both.

Sources

  1. JAMA Netw Open: Tumor Treating Fields and Quality of Life Among Patients With Locally Advanced Pancreatic Adenocarcinoma: A Secondary Analysis of a Randomized Clinical Trial (PMID 43024239 · DOI 10.1001/jamanetworkopen.2026.41241) · 2026-11-13

More on this story

Report an error